Lexeo Therapeutics vs Orchard Therapeutics
Lexeo Therapeutics vs Orchard Therapeutics, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Lexeo Therapeutics is on 61/100 and Orchard Therapeutics on 51/100.
Where each one leads
Lexeo Therapeutics
- our overall score: 61/100 against 51/100
- funding raised: $495M against $125M
Orchard Therapeutics
- domain rating: 60/100 against 41/100
- headcount: 248 against 91
- LinkedIn following: 54,964 against 16,654
At a glance
| Measure | Lexeo Therapeutics | Orchard Therapeutics |
|---|---|---|
| What it is | Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases. | Gene therapy company developing treatments for rare inherited diseases. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2020 | 2015 |
| Headquarters | New York City, United States | Boston, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Lexeo Therapeutics | Orchard Therapeutics |
|---|---|---|
| Employees | 91 | 248 |
| Total funding | $495M | $125M |
| Latest round | Public Offering | IPO |
| LinkedIn followers | 16,654 | 54,964 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Lexeo Therapeutics | Orchard Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 61/100 | 51/100 |
| Traction | 60/100 | 60/100 |
| Team | 70/100 | 30/100 |
| Community | 8/100 | Not published |
| Search visibility | 28/100 | 25/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 41/100 | 60/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Lexeo Therapeutics | Orchard Therapeutics |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Google Tag Manager | Google Tag Manager |
Lexeo Therapeutics vs Orchard Therapeutics: common questions
Which is better, Lexeo Therapeutics or Orchard Therapeutics?
On our 0-100 score Lexeo Therapeutics rates higher (61/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do Lexeo Therapeutics and Orchard Therapeutics compare on the numbers?
Lexeo Therapeutics leads on our overall score (61/100 against 51/100), funding raised ($495M against $125M). Orchard Therapeutics leads on domain rating (60/100 against 41/100), headcount (248 against 91), LinkedIn following (54,964 against 16,654).
Read the full Lexeo Therapeutics review and pricing or the Orchard Therapeutics review and pricing. You can also browse other Lexeo Therapeutics alternatives we track.